Glucocorticoids decrease the bioavailability of TGF-β which leads to a reduced TGF-β signaling in hepatic stellate cells
- 10 November 2004
- journal article
- Published by Elsevier in Biochemical and Biophysical Research Communications
- Vol. 325 (4), 1264-1270
- https://doi.org/10.1016/j.bbrc.2004.10.164
Abstract
No abstract availableKeywords
This publication has 37 references indexed in Scilit:
- Crystal Structure of the Glucocorticoid Receptor Ligand Binding Domain Reveals a Novel Mode of Receptor Dimerization and Coactivator RecognitionCell, 2002
- Betaglycan Inhibits TGF-β Signaling by Preventing Type I-Type II Receptor Complex FormationJournal of Biological Chemistry, 2002
- TGFβ1 in liver fibrosis: time to change paradigms?FEBS Letters, 2001
- Cross-talk between glucocorticoid receptor and AP-1Oncogene, 2001
- NEW EMBO MEMBERS REVIEW: Transcriptional control by the TGF-beta/Smad signaling systemThe EMBO Journal, 2000
- Molecular regulation of hepatic fibrogenesisJournal of Hepatology, 1998
- Ikappa Balpha -independent downregulation of NF-kappa B activity by glucocorticoid receptorThe EMBO Journal, 1997
- Transforming Growth Factors β1, β2, and β3 and Their Receptors Are Differentially Regulated during Normal and Impaired Wound HealingJournal of Biological Chemistry, 1996
- The Cellular Basis of Hepatic Fibrosis -- Mechanisms and Treatment StrategiesNew England Journal of Medicine, 1993
- The Steroid and Thyroid Hormone Receptor SuperfamilyScience, 1988